Akero Therapeutics, Inc. logo AKRO - Akero Therapeutics, Inc.

Inactive Ticker AKRO is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 10
HOLD 4
SELL 0
STRONG
SELL 0
| PRICE TARGET: $48.40 DETAILS
HIGH: $56.00
LOW: $38.00
MEDIAN: $54.00
CONSENSUS: $48.40
DOWNSIDE: 11.44%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 19.38
Quick Ratio 19.38
Solvency Ratio -3.326
Cash Ratio 8.56

Valuation Ratios

Ratio Value
Price/Earnings
-7.41
Peers avg: 22.6
PEG Ratio -0.25
Forward PEG -0.25
Price/Book 2.49
Price/Sales 0.00
Price/FCF -8.08
Price/Op Cash Flow -8.12

Debt Ratios

Ratio Value
Debt/Assets 0.0441
Debt/Equity 0.0486
Debt/Capital 0.0463
Long-Term Debt/Capital 0.0449
Financial Leverage 1.10

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -5.788
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.4%

Coverage Ratios

Ratio Value
Debt Service Coverage -52.99
Interest Coverage -61.1446
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage -6.31
Capital Expenditure Coverage -230.34
Dividend + Capital Expenditure Coverage -230.34

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -3.754
Debt/Share 0.6126
Cash/Share 11.07
Book Value/Share 11.17
Tangible BV/Share 11.17
Equity/Share 11.17
Operating Cash Flow/Share -3.427
Capital Expenditure/Share 0.015
FCF/Share -3.442

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.883
Price/Fair Value 2.49
Debt/Market Cap 0.0189
Effective Tax Rate 0.0%
Enterprise Value Multiple -6.32